PDF(1098 KB)
基于临床统计丹红注射液常见联合用药的药物相互作用文献研究
张倩, 居文政, 郭建明, 李建萍, 王晓骁, 戴国梁, 谭喜莹, 唐志书, 赵步长, 段金廒
中国医院药学杂志 ›› 2016, Vol. 36 ›› Issue (9) : 773-777.
PDF(1098 KB)
PDF(1098 KB)
基于临床统计丹红注射液常见联合用药的药物相互作用文献研究
A literature review on drug-drug interactions between Danhong injection and commonly combined drugs based on clinical statistics
目的:基于临床数据统计丹红注射液常见临床联用药物,并针对联用组合进行药物相互作用文献研究,为进一步开展药物相互作用实验评价,完善联合用药方案奠定基础。方法:采用回顾性研究方法,基于南京中医药大学附属医院信息系统(HIS)选取2014年1月-12月使用丹红注射液的2673例患者医嘱信息,运用基本统计和关联分析方法整理联合用药信息,并针对联用频率排序前5位的药物组合,通过CNKI、Pubmed、Web of Science与Cochrane Library检索2000年1月-2016年1月的药物相互作用文献进行研究。结果:丹红注射液临床常与抗血小板药、调血脂药和脑血管病药物联用,单项合并用药联用频次排序前5为阿司匹林、氯吡格雷、阿托伐他汀、瑞舒伐他汀和美托洛尔。多项关联分析置信度最高为丹红注射液+氯吡格雷+阿托伐他汀,其次为丹红注射液+阿司匹林+阿托伐他汀。文献检索发现丹红注射液与这些药物联用的临床效益较好,但仍潜在风险。结论:丹红注射液联合用药复杂,常与功效相近的西药联用,且文献研究表明联合用药研究以协同增效为主,为保证临床用药安全和效益,需进行系统的药物相互作用实验研究,完善联合用药方案,为中药注射剂联合用药提供示范性研究。
OBJECTIVE To obtain common drug combinations of Danhong injection (DHI) based on clinical data, summarize literatures of drug-drug interactions within the combinations,and make a foundation for investigation of herb-drug interactions between DHI and combined drugs. METHODS A retrospective study was conducted on 2673 cases of patients in HIS database of our hospital from January to December in 2014.Frequency analysis and association rule analysis were adopted to sort common drug combinations.Then drug-drug interaction literatures were searched in databases including CNKI,Pubmed,Web of Science and Cochrane Library from January 2000 to January 2016,to find out top 5 combinations. RESULTS DHI was often used with antiplatelet drugs,lipid regulating agents and cerebrovascular drugs.It was sorted in order that aspirin,clopidogrel,atorvastatin,rosuvastatin and metoprolol were the most frequently used clinical combinations.In multiple association rule analysis,combination of the highest confidence level was clopidogrel and atorvastatin,followed by aspirin and atorvastatin.It was found that clinical efficacy proved to be positive between DHI and agents according to references,but risks of drug-drug interactions still existed. CONCLUSION DHI is usually combined with western drugs of similar efficacy,which has been proved that such combination has synergistic effects.However,to guarantee clinical safety and benefits,systemic studies on drug interactions should be performed to improve medication regimen,and provide a demonstration research for combination with Chinese patent injection.
丹红注射液 / 临床联合用药 / 药物相互作用 {{custom_keyword}} /
Danhong injection / clinical drug combination / drug-drug interaction {{custom_keyword}} /
[1] 张世光.中国已上市中药注射剂品种分析报告[J].中国医院药学杂志,2015,35(5):369-374.
[2] 谭乐俊,王萌,朱彦.中药注射剂的不良反应研究进展[J].中国中药杂志,2014,39(20):3889-3898.
[3] 谢雁鸣,王连心,王永炎.临床联合用药机制研究的探讨[J].中国中药杂志,2014,39(18):3424-3426.
[4] 国家食品药品监督管理总局.国家药品不良反应监测年度报告(2013年)[EB/OL].(2014-05-14) http://www.sda.gov.cn/WS01/CL0078/99794.html.
[5] 国家食品药品监督管理总局.国家药品不良反应监测年度报告(2011年)[EB/OL].(2012-05-31) http://www.sda.gov.cn/WS01/CL0078/72193.html.
[6] 国家食品药品监督管理总局.国家食品药品监督管理局发布2012年药品不良反应监测年度报告[EB/OL].(2013-03-14) http://www.sda.gov.cn/WS01/CL0051/79058.html.
[7] 国家食品药品监督管理总局.国家药品不良反应监测年度报告(2014年)[EB/OL].(2015-07-17) http://app1.sfda.gov.cn/WS01/CL0078/124407.html.
[8] 李贵华,姜红岩,谢雁鸣,等.基于大数据84697例冠心病中医证候及其中西药使用分析[J].中国中药杂志,2014,39(18):3462-3468.
[9] 马金辉,王志飞,谢雁鸣,等.真实世界大数据30034例高血压住院患者中西医诊疗规律初探[J].中国中药杂志,2014,39(18):3435-3441.
[10] 王佳,谢雁鸣,杨薇,等.医院电子医疗数据库缺血性中风病患者临床用药特征分析[J].中国中药杂志,2014,39(18):3479-3486.
[11] 陈倩,易丹辉,谢雁鸣,等.基于HIS"真实世界"的DHI上市后临床应用分析[J].中国中药杂志,2011,36(20):2817-2820.
[12] 杜婧,杨薇,易丹辉,等.基于HIS"真实世界"的DHI治疗冠心病患者合并用药分析[J].中国中药杂志,2011,36(20):2821-2824.
[13] 张倩,居文政,郭建明,等.2013-2014年南京中医药大学附属医院丹红注射液临床用药合理性分析[J].中国中药杂志,2016,41(5):28-34.
[14] Li JP,Guo JM,Shang EX,et al.A metabolomics strategy to explore urinary biomarkers and metabolic pathways for assessment of interaction between Danhong injection and low-dose aspirin during their synergistic treatment[J].J Chromatogr B Analyt Technol Biomed Life Sci,2015,Jul 26.pii:S1570-0232(15)30112-4.
[15] Zhou LM,Wang S,Zhang Z,et al. Pharmacokinetic and pharmacodynamic interaction of Danshen-Gegen extract with warfarin and aspirin[J].J Ethnopharmacol,2012,143:648-655.
[16] Gupta D,Jalali M,Wells A,et al.Drug-herb interactions:unexpected suppression of free Danshen concentrations by salicylate[J].J Clin Lab Anal,2002,16:290-294.
[17] Sun SQ,Hao HP,Gong P,et al. Protocatechualdehyde synergizes with aspirin at the platelet cyclooxygenase-1 level[J].Planta Med,2011,77(17):1898-1904.
[18] Hankey GJ,Eikelboom JW.Aspirin resistance[J].Lancet,2006,367(9510):606-617.
[19] Liu AJ,Li HQ,Li JH,et al.Chinese herbal medicine for aspirin resistance:a systematic review of randomized controlled trials[J].Evid Based Complement Alternat Med:eCAM,2014,2014:890950.
[20] Sun SQ,Hao HP,Shi HB,et al. Caffeic Acid Reverses Nonsteroidal Anti-inflammatory Drugs-aspirin Interaction[J].Chin J Nat Med,2011,9(5):0369-0373.
[21] 王艳艳,郭旭东,于秋影,等.丹红注射液与阿司匹林合用致眼球结膜出血加重1例[J].药物流行病学杂志,2015,24(5):316-317.
[22] Lee JH,Shin YJ,Kim HJ,et al.Danshen extract does not alter pharmacokinetics of docetaxel and clopidogrel,reflecting its negligible potential in P-glycoprotein- and cytochrome P4503A-mediated herb-drug interactions[J].Int J Pharm,2011,410:68-74.
[23] 刘丽雅,韩永龙,余奇,等.10种心血管类中药注射剂对人细胞色素P4507种亚型的体外抑制作用[J].中国药房,2014,25(11):990-993.
[24] 余小翠,黄丽军,刘高峰,等.丹红注射液对大鼠肝微粒体5种CYP亚型酶活性的影响[J].医药导报,2012,31(3):277-281.
[25] Li YH,Wang NS.Antithrombotic effects of Danggui,Honghua and potential drug interaction with clopidogrel[J].J Ethnopharmacol,2010,128(3):623-628.
[26] Chen J,Deng J,Zhang YY,et al.Lipid-lowering effects of Danhong injection on hyperlipidemia rats[J].J Ethnopharmacol,2014,154:437-442.
[27] 陈娟,邓军,张宇燕,等.丹参素对高脂血症大鼠脂代谢调节机制研究[J].中国中药杂志,2015,40(2):313-317.
[28] Xu S,Liu Z,Huang Y,et al. Effectiveness of combination therapy of atorvastatin and non lipid-modifying tanshinone IIA from Danshen in a mouse model of atherosclerosis[J].Int J Cardiol,2014,174(3):878-880.
[29] 温金华,胡锦芳,蔡军,等.丹参对瑞舒伐他汀在大鼠体内药代动力学的影响[J].第二军医大学学报,2012,33(3):320-323.
[30] 温金华,魏筱华,程晓华,等.OATP1B1介导中药组份丹参素与瑞舒伐他汀的相互作用机制[J].药学学报,2016,51(1):75-79.
[31] Wen JH,Xiong YQ.The effect of herbal medicine danshensu and ursolic acid on pharmacokinetics of rosuvastatin in rats[J].Eur J Drug Metab Pharmacokinet,2011,36:205-211.
[32] Zhao D,Gao ZD,Han DE,et al. Influence of rifampicin on the pharmacokinetics of Salvianolic acid B may involve inhibition of organic anion transporting polypeptide (OATP) mediated influx[J].Phytother Res,2012,26:118-121.
[33] Wang L,Sweet DH.Active hydrophilic components of the medicinal herb Salvia mileiorrhiza (Danshen) potently inhibit organic anion transporters 1(Slc22a6) and 3(Slc22a8)[J].Evid Based Complement Alternat Med,2012:872458.
[34] Wan RZ,Zhou MJ,Liu CX.The effects of salvianolic acid B from radix Salvia miltiorrhizae on the oral pharmacokinetics of metoprolol and metoprolol acid in rats[J].Phytother Res,2010,24:846-851.
[35] Li MJ,Wang FQ,Huang YH, et al.Systemic Exposure to and Disposition of Catechols Derived from Salvia miltiorrhiza Roots (Danshen) after Intravenous Dosing DanHong Injection in Human Subjects,Rats,and Dogs[J].Drug Metab Dispos,2015,43(5):679-690.
国家重点基础研究发展计划("973计划")项目(编号:2011CB505300);国家"重大新药创制"科技重大专项(编号:2015ZX09501004001006);江苏省高校自然科学研究重大项目(编号:14KJA360001);江苏省中药资源产业化过程协同创新中心重点项目(编号:ZDXM-2-2);江苏省普通高校研究生科研创新计划项目(编号:KYLX_0968);江苏省高等学校大学生创新创业训练计划省级项目(编号:201510315064Y)
/
| 〈 |
|
〉 |
